Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma

Affiliated Hospital of Jiangnan University

Status: Completed

Conditions: Liver Carcinoma

Treatments: Radiation: 18F-RD2

Study type: Interventional

Funder types: Other

Identifiers

NCT05681234

LS2021058

Details and patient eligibility

About

This is a single arm study to evaluate the safety and biodistribution of 18F-labeled RD2 PET/CT Imaging in patients with small liver carcinoma.

Enrollment: 30 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients with highly suspected tumor；
2. Patients underwent PET/CT examination within 1 week;
3. Patients voluntarily signed informed consent;
4. Over 18 years old, male or female.

Exclusion criteria

1. Pregnant women;
2. Lactating women;
3. Patients with impaired renal function.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

18F-RD2

Experimental group

Treatment:

Radiation: 18F-RD2